Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS

OBJECTIVES: To expand the knowledge about the immunological consequences of cladribine (CLAD), a pulsed immune reconstitution therapy approved for active multiple sclerosis (MS), beyond the known short‐term effects on peripheral immune cell subsets. METHODS: In this study, we characterized depletion...

Descripción completa

Detalles Bibliográficos
Autores principales: Moser, Tobias, Schwenker, Kerstin, Seiberl, Michael, Feige, Julia, Akgün, Katja, Haschke‐Becher, Elisabeth, Ziemssen, Tjalf, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664268/
https://www.ncbi.nlm.nih.gov/pubmed/33002321
http://dx.doi.org/10.1002/acn3.51206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664268/
https://www.ncbi.nlm.nih.gov/pubmed/33002321
http://dx.doi.org/10.1002/acn3.51206

Ejemplares similares